First Trust Nasdaq Pharmaceuticals ETF
FTXH
NASDAQ
| Weiss Ratings | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Reward Grade | B- | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Valuation | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $41.09 | |||
| Company Info | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | First Trust | |||
| Manager/Tenure (Years) | Jon C. Erickson (9), Daniel J. Lindquist (9), David G. McGarel (9), 4 others | |||
| Website | http://www.ftportfolios.com/ | |||
| Phone Number | 800-621-1675 | |||
| Fund Information | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | First Trust Nasdaq Pharmaceuticals ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Sep 20, 2016 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.03% | |||
| Dividend | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.40% | |||
| Asset Allocation | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.14% | |||
| Stock | 99.85% | |||
| U.S. Stock | 99.33% | |||
| Non-U.S. Stock | 0.52% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.44% | |||
| 30-Day Total Return | 0.94% | |||
| 60-Day Total Return | 6.31% | |||
| 90-Day Total Return | 16.26% | |||
| Year to Date Total Return | 25.10% | |||
| 1-Year Total Return | 46.97% | |||
| 2-Year Total Return | 43.87% | |||
| 3-Year Total Return | 62.71% | |||
| 5-Year Total Return | 71.71% | |||
| Price | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $41.40 | |||
| 1-Month Low Price | $40.47 | |||
| 1-Month High Price | $42.76 | |||
| 52-Week Low Price | $27.30 | |||
| 52-Week Low Price (Date) | Sep 25, 2025 | |||
| 52-Week High Price | $42.76 | |||
| 52-Week High Price (Date) | Aug 25, 2026 | |||
| NAV | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $40.41 | |||
| 1-Month High NAV | $42.72 | |||
| 52-Week Low NAV | $27.32 | |||
| 52-Week Low NAV (Date) | Sep 25, 2025 | |||
| 52-Week High NAV | $42.72 | |||
| 52-Week High Price (Date) | Aug 25, 2026 | |||
| Beta / Standard Deviation | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.42 | |||
| Standard Deviation | 14.71 | |||
| Balance Sheet | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.05B | |||
| Operating Ratios | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.60% | |||
| Turnover Ratio | 35.00% | |||
| Performance | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 38.88% | |||
| Last Bear Market Total Return | -0.31% | |||